Join
Live feed
·
PRReleasevia Quantisnow
CohBar Inc. logo

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

ByQuantisnow·Wall Street's wire, on your screen.
CWBR· CohBar Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CWBR (CohBar Inc.) and more on Quantisnow.